Loading data for CBLL — first visit, this takes a few seconds.

알림

CeriBell Inc. (CBLL)

NasdaqGS: CBLL · 실시간 가격 · USD

23.33

+0.08 (0.34%)

종가 기준: Aug 18, 2026, 3:59 PM

0.34% (1D)

매수호가	16.79
시가총액	970.2M
매출 (ttm)	101.96M
순이익 (ttm)	-66M
베타	n/a
EPS (ttm)	-1.76
P/E (ttm)	n/a
선행 P/E	-16.45
P/B (ttm)	7.53
P/S (ttm)	9.52
Earnings Date	Nov 3, 2026

매도호가	29.72
거래량	296,039
평균 거래량 (20일)	373,722
시가	23.25
전일 종가	23.25
일중 범위	23.03 - 23.55
52주 범위	10.85 - 24.33
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

CBLL 소개

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered sei...

[더 보기]

산업 Medical Devices

섹터 Healthcare

IPO 일자 Oct 11, 2024

직원 수 327

상장 거래소 NasdaqGS

티커 CBLL

웹사이트 https://www.ceribell.com

전체 기업 정보

재무 실적

2025년 CeriBell의 매출은 89.06M로, 전년 65.44M 대비 36.09% 증가했습니다. 순이익은 -53.41M로, 32.03% 증가했습니다.

재무제표

어닝 서프라이즈

CeriBell가 Aug 10, 2026에 분기 실적을 발표했습니다:

매출 $26.49M 예상치 하회 $0, 및 29.30% 전년 대비 성장.

EPS -0.4 예상치 상회 0.06, 및 -5.26% 전년 대비 감소.

다음 실적 발표

CeriBell Inc.의 실적 발표 예정일은 Nov 3, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

6일 전 · MarketBeat

CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push

CeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it co...

1주 전 · GuruFocus.com

CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...

Strong growth driven by new FDA clearances, Delirium NTAP approval, and expanding account base despite widening net losses.

1주 전 · Moby

CeriBell, Inc. Q2 2026 Earnings Call Summary

Moby summary of CeriBell, Inc.'s Q2 2026 earnings call

1주 전 · Motley Fool

CeriBell (CBLL) Q2 2026 Earnings Call Transcript

Revenue surged 33% as hospital accounts expanded and delirium reimbursement neared launch.

1주 전 · Zacks

Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings

Although the revenue and EPS for CeriBell, Inc. (CBLL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall S...

2 페이지 중 1

CeriBell Inc. (CBLL)